Home › Encyclopedia › Kisspeptin: Research Status and Clinical Trial Overview
Research / Unapproved

Kisspeptin: Research Status and Clinical Trial Overview

Molecular formulaC258H401N79O78
Molecular weight5857 g/mol
Registered trials45
PubChem CID71306396

What Kisspeptin Is

Kisspeptin is a peptide compound, cataloged under PubChem CID 71306396, with no FDA-approved label or indication. It is not approved for any medical use and remains classified as a research compound. There is no sponsor-submitted label describing an approved mechanism of action, dosing, or safety profile for kisspeptin.

Clinical Trial Landscape

Kisspeptin has been studied across 45 registered clinical trials. Among the available trial records, one study examined neuropeptide stimulation through a recall-by-genotype design but was terminated. Another trial investigating age-dependent changes in the hypothalamic pituitary gonadal axis in men reached completion. A separate, currently recruiting trial is evaluating neuro-reproductive function in obese adolescent females with polycystic ovary syndrome, though this study centers on a different agent studied in parallel with kisspeptin-related pathways. These trials span early exploratory work through later-stage designs, reflecting a research compound still under active investigation rather than one with an established clinical role.

FAQ

Is kisspeptin FDA approved?
No. Kisspeptin has no FDA-approved label or indication. It is currently studied only as an investigational research compound.
What is kisspeptin used for in research?
Kisspeptin is being studied in clinical trials related to neuroendocrine and reproductive hormone signaling, including hypothalamic pituitary gonadal axis function. None of this research has led to an approved use.
How many clinical trials have studied kisspeptin?
There are 45 registered clinical trials involving kisspeptin. These range from early-phase mechanistic studies to larger completed trials, with some still recruiting participants.
Has any kisspeptin trial been stopped early?
Yes. One trial examining neuropeptide stimulation through a recall-by-genotype approach was terminated before completion. The available data does not specify the reason for termination.
Does kisspeptin have a known chemical structure?
Yes, kisspeptin is a large peptide compound with a defined molecular formula and structure, cataloged in PubChem under CID 71306396. This structural identity does not imply any approved therapeutic use.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 71306396 ClinicalTrials.gov

Updated 2026-11-07